Stada Adds To Consumer Business With Sanofi Deal
Transaction Covers 16 Brands Across 13 European Markets
Stada has expanded its business with another acquisition in the consumer healthcare space, this time striking a deal with Sanofi for 16 brands across 13 European markets.
You may also be interested in...
Roche gives back choroideremia candidate to 4D Molecular after reviewing Phase I data, partners on synthetic GI therapy with Synlogic. AbbVie opts to acquire TeneoOne under 2019 agreement.
With group sales rising by double digits in 2019, Stada says it has the firepower to accelerate investment not only in the firm’s own product development but also broadly into external co-development and product in-licensing, to support sustainability and long-term growth.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.